120 related articles for article (PubMed ID: 8923864)
1. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Witchel SF; Bhamidipati DK; Hoffman EP; Cohen JB
J Clin Endocrinol Metab; 1996 Nov; 81(11):4081-8. PubMed ID: 8923864
[TBL] [Abstract][Full Text] [Related]
2. Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency.
Witchel SS; Lee PA; Trucco M
Am J Med Genet; 1996 Jan; 61(1):2-9. PubMed ID: 8741909
[TBL] [Abstract][Full Text] [Related]
3. CYP21 mutations in Brazilian patients with 21-hydroxylase deficiency.
Witchel SF; Smith R; Crivellaro CE; Della Manna T; Dichtchekenian V; Setian N; Damiani D
Hum Genet; 2000 Apr; 106(4):414-9. PubMed ID: 10830908
[TBL] [Abstract][Full Text] [Related]
4. Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance.
Chin D; Speiser PW; Imperato-McGinley J; Dixit N; Uli N; David R; Oberfield SE
J Clin Endocrinol Metab; 1998 Jun; 83(6):1940-5. PubMed ID: 9626123
[TBL] [Abstract][Full Text] [Related]
5. An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia.
Lajic S; Wedell A
Hum Genet; 1996 Aug; 98(2):182-4. PubMed ID: 8698338
[TBL] [Abstract][Full Text] [Related]
6. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
[TBL] [Abstract][Full Text] [Related]
7. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.
Witchel SF; Lee PA
Am J Med Genet; 1998 Apr; 76(4):337-42. PubMed ID: 9545098
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for 21-hydroxylase deficiency: results of CYP21 molecular genetic analysis.
Witchel SF; Nayak S; Suda-Hartman M; Lee PA
J Pediatr; 1997 Aug; 131(2):328-31. PubMed ID: 9290628
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore.
Loke KY; Lee YS; Lee WW; Poh LK
Horm Res; 2001; 55(4):179-84. PubMed ID: 11598371
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.
Tajima T; Fujieda K; Nakayama K; Fujii-Kuriyama Y
J Clin Invest; 1993 Nov; 92(5):2182-90. PubMed ID: 8227333
[TBL] [Abstract][Full Text] [Related]
11. Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese.
Lee HH; Chao HT; Lee YJ; Shu SG; Chao MC; Kuo JM; Chung BC
Hum Genet; 1998 Sep; 103(3):304-10. PubMed ID: 9799085
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U
Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
[TBL] [Abstract][Full Text] [Related]
13. de novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings.
Tajima T; Fujieda K; Fujii-Kuriyama Y
J Clin Endocrinol Metab; 1993 Jul; 77(1):86-9. PubMed ID: 8325964
[TBL] [Abstract][Full Text] [Related]
14. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.
Barbat B; Bogyo A; Raux-Demay MC; Kuttenn F; Boué J; Simon-Bouy B; Serre JL; Mornet E
Hum Mutat; 1995; 5(2):126-30. PubMed ID: 7749410
[TBL] [Abstract][Full Text] [Related]
15. Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase.
Schulze E; Scharer G; Rogatzki A; Priebe L; Lewicka S; Bettendorf M; Hoepffner W; Heinrich UE; Schwabe U
Endocr Res; 1995; 21(1-2):359-64. PubMed ID: 7588399
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic evolution of classic 21-hydroxylase deficiency.
Hoffman WH; Shin MY; Donohoue PA; Helman SW; Brown SL; Rosculet G; Mahesh VB
Clin Endocrinol (Oxf); 1996 Jul; 45(1):103-9. PubMed ID: 8796146
[TBL] [Abstract][Full Text] [Related]
17. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Speiser PW; Dupont J; Zhu D; Serrat J; Buegeleisen M; Tusie-Luna MT; Lesser M; New MI; White PC
J Clin Invest; 1992 Aug; 90(2):584-95. PubMed ID: 1644925
[TBL] [Abstract][Full Text] [Related]
18. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
Owerbach D; Ballard AL; Draznin MB
J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489
[TBL] [Abstract][Full Text] [Related]
19. A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia. Mutations in brief no. 247. Online.
Kapelari K; Ghanaati Z; Wollmann H; Ventz M; Ranke MB; Kofler R; Peters H
Hum Mutat; 1999; 13(6):505. PubMed ID: 10408786
[TBL] [Abstract][Full Text] [Related]
20. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.
Wilson RC; Mercado AB; Cheng KC; New MI
J Clin Endocrinol Metab; 1995 Aug; 80(8):2322-9. PubMed ID: 7629224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
